Showing 3,741 - 3,760 results of 4,870 for search '"pharmacy"', query time: 0.06s Refine Results
  1. 3741
  2. 3742

    Psychological Distress among Pharmacists during Second Wave of Pandemic: A Cross-Sectional Study by Keshav Dhakal, Shobhana Nepal, Pratigya Sapkota

    Published 2022-01-01
    “…A cross-sectional analytical design was adopted to study the psychological distress of pharmacists working in community pharmacies in Bharatpur. Materials and Methods. Purposive sampling method was used to select 172 community pharmacists. …”
    Get full text
    Article
  3. 3743
  4. 3744
  5. 3745
  6. 3746
  7. 3747
  8. 3748
  9. 3749
  10. 3750

    Patenting of an Invention and an Utility Model Whose Object Is an Innovative Medicinal Product by S. V. Vasyliev

    Published 2021-07-01
    “…Gaps and inconsistencies have been identified in the legislation that regulates intellectual property rights protection in the field of pharmacy. In particular, contradictions in the legal regulation of the examination of applications for a patent for an invention or utility model, the objects of which are innovative medicinal products. …”
    Get full text
    Article
  11. 3751
  12. 3752
  13. 3753
  14. 3754

    Usual prevention in unusual settings: A scoping review of place-based health interventions in public-facing businesses. by Jack Tsai, Nicholas A McCann

    Published 2025-01-01
    “…The most common unconventional public-facing business settings for health interventions included barbershops or beauty salons; interventions included health education, preventative screenings, pharmacy services, and connections to local healthcare providers and resources. …”
    Get full text
    Article
  15. 3755
  16. 3756

    Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazi... by Victor W. Sung, Sanjay K. Gandhi, Victor Abler, Brian Davis, Debra E. Irwin, Karen E. Anderson, Ravi G. Iyer

    Published 2018-01-01
    “…During the 6-month post-index period after HD diagnosis, HD patients incurred higher all-cause healthcare costs ($20 204) vs the 6-month pre-index period ($6057), driven by higher hospitalization and pharmacy costs. **Conclusions:** A small percentage of HD patients with chorea were treated with tetrabenazine and discontinuation rates were high among those receiving treatment, with a median time to discontinuation of 9 months.…”
    Get full text
    Article
  17. 3757
  18. 3758
  19. 3759
  20. 3760